Jefferies Starts Insmed (INSM) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $107.93 +3.34%
Rating Summary:
31 Buy, 2 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 25 | New: 12
Rating Summary:
31 Buy, 2 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 25 | New: 12
Join SI Premium – FREE
Jefferies analyst Faisal Khurshid initiates coverage on Insmed (NASDAQ: INSM) with a Buy rating and a price target of $228.00.
For an analyst ratings summary and ratings history on Insmed click here. For more ratings news on Insmed click here.
Shares of Insmed closed at $139.50 yesterday.
You May Also Be Interested In
- Insmed (INSM) PT Lowered to $201 at Guggenheim
- Citi Starts TCL Electronics Holdings (1070:HK) at Buy
- UBS Starts Orbbec Inc (688322:CH) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
